Jinhai Medical Technology Limited (Jinhai MedTech) filed its Monthly Return for Equity Issuer for the period ended 31 August 2026, confirming an unchanged share base and full compliance with Hong Kong’s public-float rules.
Authorised Share Capital • Authorised share capital stood at 8.00 billion ordinary shares with a par value of HKD 0.0025, equivalent to HKD 20.00 million. No changes were recorded during the month.
Issued Shares and Public Float • Issued shares remained at 5.30 billion, with zero treasury shares on record. • The company affirmed that at least 25 % of its issued shares were held in public hands, meeting Main Board Rule 13.32B requirements.
Share Option Position • Under the Share Option Scheme adopted on 29 December 2023, 445.96 million options were outstanding at month-end, unchanged from July 2026. • No options were exercised, and no new shares were issued or treasury shares transferred. Consequently, no proceeds were raised from option exercises.
Other Equity Instruments • The company reported no outstanding warrants, convertible securities, or other share-issuance arrangements. • There were no share repurchases, cancellations, or redemptions during the month.
Regulatory Confirmation • The filing was signed by Company Secretary Wong Man Yiu, confirming compliance with all relevant listing rules and regulatory requirements.
Comments